Goldman Sachs’s Select Medical SEM Stock Holding History

Goldman Sachs’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-2,042	Closed	-$20K	–	5770
2018 Q2	$20K	Sell	2,042 -16,889	-89%	-$166K	﹤0.01%	5492
2018 Q1	$176K	Sell	18,931 -9,837	-34%	-$93.7K	﹤0.01%	5061
2017 Q4	$274K	Buy	28,768 +23,386	+435%	+$223K	﹤0.01%	5229
2017 Q3	$56K	Buy	5,382 +4,640	+625%	+$42.8K	﹤0.01%	6228
2017 Q2	$6K	Buy	+742	New	+$5.57K	﹤0.01%	6686
2016 Q4	–	Sell	-557	Closed	-$4K	–	7070
2016 Q3	$4K	Sell	557 -2,227	-80%	-$14.2K	﹤0.01%	6937
2016 Q2	$16K	Buy	2,784 +557	+25%	+$3.69K	﹤0.01%	6776
2016 Q1	$14K	Buy	2,227 +371	+20%	+$1.99K	﹤0.01%	6835
2015 Q4	$12K	Sell	1,856 -2,042	-52%	-$12.8K	﹤0.01%	6943
2015 Q3	$23K	Sell	3,898 -29,510	-88%	-$219K	﹤0.01%	7002
2015 Q2	$292K	Sell	33,408 -18,003	-35%	-$151K	﹤0.01%	5769
2015 Q1	$411K	Buy	+51,411	New	+$384K	﹤0.01%	5337
2014 Q4	–	Sell	-1,670	Closed	-$11K	–	7293
2014 Q3	$11K	Buy	1,670 +742	+80%	+$5.73K	﹤0.01%	7044
2014 Q2	$8K	Sell	928 -1,856	-67%	-$14.4K	﹤0.01%	6930
2014 Q1	$19K	Buy	+2,784	New	+$16.9K	﹤0.01%	6687

Other funds holding SEM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Goldman Sachs's SEM Position: Q1 2026 in Review

Goldman Sachs increased its Select Medical (SEM) stake by 319% in Q1 2026, buying an estimated $24.8M and bringing the position to 2,081,883 shares worth $33.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1925.

Goldman Sachs first reported a position in SEM in Q2 2013 and has held it in 52 quarters since. The position peaked at $80.5M in Q2 2021. 277 funds tracked by Wall St. Rank hold SEM as of Q1 2026.

Goldman Sachs held 2,081,883 shares of Select Medical worth $33.9M as of Q1 2026.
Goldman Sachs bought 1,585,237 Select Medical shares in Q1 2026, an estimated $24.8M.
Select Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #1925 holding.
Goldman Sachs first reported a position in Select Medical in Q2 2013 and has held it in 52 quarters since.
Goldman Sachs's Select Medical position peaked at $80.5M in Q2 2021.
277 funds tracked by Wall St. Rank held Select Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.